Centiva Capital, LP - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217117. A total of 66 filers reported holding BIOPLUS ACQUISITION CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Centiva Capital, LP ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q3 2023$4,623,728
+1.7%
426,9370.0%0.10%
+2.0%
Q2 2023$4,546,879
+347.1%
426,937
+338.3%
0.10%
+300.0%
Q1 2023$1,017,023
-49.2%
97,416
-50.0%
0.02%
-10.7%
Q4 2022$2,002,872
+104.6%
194,832
+100.0%
0.03%
+55.6%
Q3 2022$979,000
-5.7%
97,416
-5.7%
0.02%
-28.0%
Q2 2022$1,038,000
+5.1%
103,250
+3.2%
0.02%
+31.6%
Q1 2022$988,000100,0000.02%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 66,607$669,0000.79%
MMCAP International Inc. SPC 650,000$6,461,0000.52%
Union Square Park Capital Management, LLC 50,000$499,0000.51%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,412,107$14,192,0000.32%
SONA ASSET MANAGEMENT (US) LLC 30,000$298,0000.29%
Lynwood Capital Management Inc. 25,000$249,0000.28%
KIM, LLC 500,000$5,025,0000.24%
Saba Capital Management, L.P. 1,791,845$17,945,0000.21%
MANGROVE PARTNERS IM, LLC 405,141$4,027,0000.20%
ROBINSON CAPITAL MANAGEMENT, LLC 26,586$265,0000.20%
View complete list of BIOPLUS ACQUISITION CORP shareholders